Heart Failure POC and LOC Devices Market Size, Share, Trends, and Growth Outlook

Heart Failure POC and LOC Devices Market is estimated to increase at a growth rate of 16.9% CAGR over the forecast period from 2024 to 2030.

 

The Heart Failure POC and LOC Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Test Type (Proteomic testing, Metabolomic testing, Genomic testing), By Technology (Microfluidics, Array-based systems, Others), By End-User (Clinics, Hospitals, Home, Assisted living healthcare facilities, Laboratory).

 

An Introduction to Heart Failure POC and LOC Devices Market in 2024

The heart failure point-of-care (POC) and lab-on-a-chip (LOC) devices market in 2024 caters to the demand for portable, rapid, and accurate diagnostic devices and monitoring tools used in the early detection, risk stratification, and management of heart failure, a chronic condition characterized by impaired cardiac function and fluid overload, which poses significant clinical and economic burdens on healthcare systems worldwide. POC and LOC devices enable healthcare providers to assess cardiac biomarkers, such as B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), electrolyte levels, and hemodynamic parameters, at the point of care or in non-laboratory settings, facilitating timely intervention, treatment optimization, and patient monitoring in heart failure management. Market dynamics are driven by factors such as the rising prevalence of heart failure, the shift towards personalized medicine, and the demand for decentralized diagnostic solutions that empower patients and caregivers to manage chronic conditions more effectively and improve clinical outcomes. Collaboration between POC and LOC device manufacturers, healthcare providers, and research institutions drives innovation and market growth in heart failure diagnostics and monitoring solutions, enabling more proactive, patient-centered approaches to heart failure care and management.

 

Heart Failure POC and LOC Devices Market Trend: Miniaturization and Portability

A prominent trend in the Heart Failure Point-of-Care (POC) and Lab-on-a-Chip (LOC) Devices market is the miniaturization and portability of diagnostic tools. Advances in microfluidics, biosensors, and nanotechnology have enabled the development of compact and handheld devices capable of detecting biomarkers associated with heart failure. These portable devices offer convenience, rapid results, and point-of-care testing, allowing for timely diagnosis and monitoring of heart failure patients in various healthcare settings, including clinics, emergency departments, and home care settings.

Heart Failure POC and LOC Devices Market Driver: Increasing Prevalence of Heart Failure

A significant driver in the Heart Failure POC and LOC Devices market is the increasing prevalence of heart failure globally. With heart failure being a leading cause of morbidity and mortality worldwide, there is a growing demand for accessible and efficient diagnostic solutions to aid in the early detection, management, and monitoring of this chronic condition. Factors such as aging populations, rising incidence of cardiovascular risk factors (e.g., hypertension, diabetes), and improvements in healthcare infrastructure contribute to the escalating burden of heart failure, driving the need for innovative POC and LOC devices to support timely interventions and improve patient outcomes.

Heart Failure POC and LOC Devices Market Opportunity: Remote Monitoring and Telehealth Integration

An opportunity for market growth in the Heart Failure POC and LOC Devices market lies in the integration of remote monitoring and telehealth solutions. As healthcare systems transition towards value-based care models and prioritize remote patient management, there is an increasing emphasis on leveraging technology to enable continuous monitoring of heart failure patients outside traditional healthcare settings. POC and LOC devices capable of remote data transmission and connectivity with telehealth platforms facilitate real-time monitoring of vital signs and biomarkers, enabling early detection of worsening heart failure symptoms, medication adjustments, and timely interventions. This convergence of diagnostic devices with telemedicine technologies presents opportunities for market players to develop comprehensive remote monitoring solutions that improve patient engagement, enhance care coordination, and reduce healthcare costs associated with heart failure management.

 

Heart Failure POC and LOC Devices Market Segmentation

By Test Type

Proteomic testing

Metabolomic testing

Genomic testing

 

By Technology

Microfluidics

Array-based systems

Others

 

By End-User

Clinics

Hospitals

Home

Assisted living healthcare facilities

Laboratory

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Heart Failure POC and LOC Devices Market Companies

Abaxis Inc

Abbott

bioMérieux S.A

Danahar

F. Hoffmann-La Roche Ltd

Quidel Corp

Siemens Healthineers

Trinity BiotechInstrumentation Laboratory

*- List Not Exhaustive

 

Reasons to Buy the Heart Failure POC and LOC Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Heart Failure POC and LOC Devices Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Heart Failure POC and LOC Devices Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Heart Failure POC and LOC Devices Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Heart Failure POC and LOC Devices Market Size Outlook, $ Million, 2021 to 2030

3.2 Heart Failure POC and LOC Devices Market Outlook by Type, $ Million, 2021 to 2030

3.3 Heart Failure POC and LOC Devices Market Outlook by Product, $ Million, 2021 to 2030

3.4 Heart Failure POC and LOC Devices Market Outlook by Application, $ Million, 2021 to 2030

3.5 Heart Failure POC and LOC Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Heart Failure POC and LOC Devices Market Industry

4.2 Key Market Trends in Heart Failure POC and LOC Devices Market Industry

4.3 Potential Opportunities in Heart Failure POC and LOC Devices Market Industry

4.4 Key Challenges in Heart Failure POC and LOC Devices Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Heart Failure POC and LOC Devices Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Heart Failure POC and LOC Devices Market Outlook By Segments

7.1 Heart Failure POC and LOC Devices Market Outlook by Segments

By Test Type

Proteomic testing

Metabolomic testing

Genomic testing

By Technology

Microfluidics

Array-based systems

Others

By End-User

Clinics

Hospitals

Home

Assisted living healthcare facilities

Laboratory

 

8 North America Heart Failure POC and LOC Devices Market Analysis And Outlook To 2030

8.1 Introduction to North America Heart Failure POC and LOC Devices Markets in 2024

8.2 North America Heart Failure POC and LOC Devices Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Heart Failure POC and LOC Devices Market size Outlook by Segments, 2021-2030

By Test Type

Proteomic testing

Metabolomic testing

Genomic testing

By Technology

Microfluidics

Array-based systems

Others

By End-User

Clinics

Hospitals

Home

Assisted living healthcare facilities

Laboratory

 

9 Europe Heart Failure POC and LOC Devices Market Analysis And Outlook To 2030

9.1 Introduction to Europe Heart Failure POC and LOC Devices Markets in 2024

9.2 Europe Heart Failure POC and LOC Devices Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Heart Failure POC and LOC Devices Market Size Outlook By Segments, 2021-2030

By Test Type

Proteomic testing

Metabolomic testing

Genomic testing

By Technology

Microfluidics

Array-based systems

Others

By End-User

Clinics

Hospitals

Home

Assisted living healthcare facilities

Laboratory

 

10 Asia Pacific Heart Failure POC and LOC Devices Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Heart Failure POC and LOC Devices Markets in 2024

10.2 Asia Pacific Heart Failure POC and LOC Devices Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Heart Failure POC and LOC Devices Market size Outlook by Segments, 2021-2030

By Test Type

Proteomic testing

Metabolomic testing

Genomic testing

By Technology

Microfluidics

Array-based systems

Others

By End-User

Clinics

Hospitals

Home

Assisted living healthcare facilities

Laboratory

 

11 South America Heart Failure POC and LOC Devices Market Analysis And Outlook To 2030

11.1 Introduction to South America Heart Failure POC and LOC Devices Markets in 2024

11.2 South America Heart Failure POC and LOC Devices Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Heart Failure POC and LOC Devices Market size Outlook by Segments, 2021-2030

By Test Type

Proteomic testing

Metabolomic testing

Genomic testing

By Technology

Microfluidics

Array-based systems

Others

By End-User

Clinics

Hospitals

Home

Assisted living healthcare facilities

Laboratory

 

12 Middle East And Africa Heart Failure POC and LOC Devices Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Heart Failure POC and LOC Devices Markets in 2024

12.2 Middle East and Africa Heart Failure POC and LOC Devices Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Heart Failure POC and LOC Devices Market size Outlook by Segments, 2021-2030

By Test Type

Proteomic testing

Metabolomic testing

Genomic testing

By Technology

Microfluidics

Array-based systems

Others

By End-User

Clinics

Hospitals

Home

Assisted living healthcare facilities

Laboratory

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Abaxis Inc

Abbott

bioMérieux S.A

Danahar

F. Hoffmann-La Roche Ltd

Quidel Corp

Siemens Healthineers

Trinity BiotechInstrumentation Laboratory

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Heart Failure POC and LOC Devices Market Segmentation

By Test Type

Proteomic testing

Metabolomic testing

Genomic testing

 

By Technology

Microfluidics

Array-based systems

Others

 

By End-User

Clinics

Hospitals

Home

Assisted living healthcare facilities

Laboratory

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)